Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Desmopressin [5] DDAVP; DESMOPRESSIN; Desmopressin Acetate; Desmopressine; Minirin[2] D00291 ,
D02235 		[2] AVPR2,
F8 💬		[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[6] 6, 64, 72, 75, 225, 288
2 Empagliflozin [2] Empagliflozin; Jardiance[1] D10459 [1] SLC5A2 💬-[5] 65, 72, 96, 97, 257
3 Exenatide [3] BYDUREON; Byetta; EXENATIDE[1] D04121 [1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[6] 6, 17, 72, 78, 193, 233
4 Oxytocin [2] Oxytocin; Syntocinon[1] D00089 [1] OXTR 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[6] 6, 72, 127, 193, 206, 226
5 Satavaptan [1] Satavaptan---[1] 72
6 Tolvaptan [3] Jinarc; Samsca; TOLVAPTAN[1] D01213 [1] AVPR2 💬[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[3] 67, 72, 225
7 Urea [1] Urea[2] D00023 ,
D01749 		--[2] 72, 251